期刊文献+

肝癌术中输血风险评分模型的建立 被引量:3

Establishment of a risk scoring model to predict intraoperative blood transfusion in patients with hepatocellular carcinoma undergoing liver surgery
原文传递
导出
摘要 目的建立肝癌术中输血风险评分(TRS)模型,预测术中输血概率。方法回顾性分析352例肝癌手术患者的临床资料。采用χ^2检验对输血组和未输血组的指标进行单因素分析,将P〈0.1的因子进一步纳入多因素Logistic回归分析。用多因素分析P〈0.05的因子构建肝癌TRS模型,采用ROC曲线评价模型的性能。结果352例肝癌患者术中输血92例,输血率为26.1%。单因素分析显示天冬氨酸转氨酶(AST)、谷氨酰基转移酶、白蛋白(Alb)、凝血酶原时间、肿瘤分期、肿瘤大小、肿瘤位置、侵犯或紧邻大血管、切肝段数和手术时长对术中输血有影响。多因素分析显示AST〉40U/L、Alb〈35g/L、肿瘤≥5cm、肿瘤位于右叶、侵犯或紧邻大血管、手术时长〉3h是术中输血的独立危险因素。设定Alb〈35g/L为2分,其他因子均为1分,计算每例患者的总分值即为TRS。TRS在0—6分范围对应的输血概率依次为0、3.8%、20.0%、35.7%、53.3%、84.6%、100%,人均输血量依次为0、0.2、0.8、1.7、3.7、5.7、8.0U,TRS与输血概率和人均输血量显著正相关(P〈0.05)。TRS模型的ROC曲线下面积为0.795。以3分为是否输血的临界值,敏感度73.9%,特异度70.4%。结论TRS模型对肝癌术中输血具有较好的预测能力,可为肝癌手术合理备血提供指导。 Objective To establish a risk scoring model to predict the likelihood of intraoperative blood transfusion in patients with hepatocellular carcinoma (HCC) undergoing liver surgery. Methods The clinical data of 352 patients with HCC who underwent liver surgery were retrospectively analyzed. The data for transfused and non-transfused patients were compared using univariate analysis. Significant variables were then entered into a multiple logistic regression model. Variables that remained in the final logistic regression analysis were used to build a transfusion risk scoring (TRS) model. The predictive value of this model was validated using ROC curves. Results Of 352 patients, 92 patients (26.1% ) received intraoperative blood transfusion. Univariate analysis showed the foil.owing ten factors to be associated with blood transfusion: aspartate aminotransferase ( AST), γ-glutamyl transpeptidase, albumin, prothrombin time, tumor stage, tumor size, location of tumor, great vessels invasion, number of liver segments resected and operation time. Logistic regression analysis identified six predictive factors of blood transfusion: AST 〉 40 U/L, albumin 〈35 g/L, tumor size≥5 cm, tumor in right liver, great vessels invasion and operation time 〉3 h. To calculate the total score of TRS for each patient, "albumin 〈 35 g/L" was assigned two points, and the other factors were assigned one point. The transfusion probabilities corresponding to the different TRS between 0 to 6 were 0, 3.8% , 20.0% , 35.7% , 53.3%, 84.6%, 100% , respectively; and the corresponding amount of blood transfusion per patient was 0, 0.2, 0.8, 1.7, 3.7, 5.7, 8.0 U, respectively. TRS was significantly and positively correlated to the transfusion probability and the amount of blood transfusion per patient (P 〈 0.05 ). The area under the ROC curve for the TRS model was 0. 795. When a score of 3 for TRS was set as the cut-off value for transfusion, the sensitivity was 73.9%, and the specificity was 70.4%. Conclusion The
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2015年第12期802-805,共4页 Chinese Journal of Hepatobiliary Surgery
基金 中国癌症基金会北京希望马拉松专项基金资助(LC2015B03)
关键词 肝癌 术中输血 风险评分 Hepatocellular carcinoma Intraoperative blood transfusion Risk scoring
  • 相关文献

参考文献12

  • 1刘立国,吴健雄,荣维淇,王黎明,钟宇新,吴凡,金晶,任骅,徐泉,王一澎,苗成利,余微波,王维虎.中央型肝癌手术切除联合放疗的临床研究[J].中华肝胆外科杂志,2013,19(5):340-342. 被引量:12
  • 2Mariette D, Smadja C, Naveau S, et al. Preoperative predictors of blood transfusion in liver resection for tumor[ J]. Am J Surg, 1997,173(4) :275-279. 被引量:1
  • 3Pulitano C, Arru M, Bellio L, et al. A risk score for predicting perioperative blood transfusion in liver surgery [ J ]. Br J Surg, 2007,94(7) :860-865. 被引量:1
  • 4吴凡,王黎明,吴健雄,刘立国,荣维淇,余微波,安松林,刘发强,冯莉,田斐.巨大肝癌外科治疗的预后影响因素[J].中华肝胆外科杂志,2014,20(5):328-332. 被引量:26
  • 5Huang G, Lai EC, Lau WY, et al. Posthepatectomy HBV reacti- vation in hepatitis B-related hepatecellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels[J]. Ann Surg, 2013,257(3) :490-505. 被引量:1
  • 6Liu L, Miao R, Yang H, et al. ProgNostic factors after liver resec- tion for hepatocellular carcinoma: a single-center experience from China[ J ]. Am J Surg, 2012,203 (6) :741-750. 被引量:1
  • 7Wang CC, Iyer SG, Low JK, et al. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepa- tectomy for hepatocellular carcinoma[ J ]. Ann Surg Oncol, 2009, 16(7) :1832-1842. 被引量:1
  • 8陈启斌,荚卫东,许戈良,马金良,李建生,葛勇胜,余继海.肝癌肝切除的输血因素分析[J].中国普通外科杂志,2011,20(7):687-690. 被引量:7
  • 9Sima CS, Jarnagin WR, Fong Y, et al. Predicting the risk of peri- operative transfusion for patients undergoing elective hepateetomy [ J]. Ann Surg, 2009,250(6) :914-921. 被引量:1
  • 10Janny S, Eurin M, Dokmak S, et al. Assessment of the external validity of a predictive score for blood transfusion in liver surgery [J]. HPB, 2015 ,17(4) :357-361. 被引量:1

二级参考文献57

  • 1徐立,石明,张亚奇,李锦清.肝细胞癌手术切缘对患者术后复发与生存的影响[J].中华肿瘤杂志,2006,28(1):47-49. 被引量:16
  • 2Bong-Wan Kim,Young-Bae Kim,Hee-Jung Wang,Myung-Wook Kim.Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(1):99-104. 被引量:19
  • 3Xiao-Ping Chen Fa-Zu Qiu Zai-De Wu Bi-Xiang Zhang.Hepatectomy for huge hepatocellular carcinoma in 634 cases[J].World Journal of Gastroenterology,2006,12(29):4652-4655. 被引量:16
  • 4Bui I,L, Smith AJ, Bercovici M, et al. Minimising blood loss and transfusion requirements in hepatic resection [J]. HPB(Oxford) , 2002, 4(1) : 5 - 10. 被引量:1
  • 5Mariette D, Smadja C, Naveau S, et al. Preoperative predictors of blood transfusion in liver resection for tumor [ J ] . Am J Surg, 1997, 173(4) : 275 -279. 被引量:1
  • 6Nagino M , Kamiya J, Arai T, et al. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome[J]. Surgery, 2005, 137(2) : 148 - 155. 被引量:1
  • 7Pulitano C, Arru M, Bellio L, et al. A risk score lot predicting per]operative blood transfusion in liver surgery[J] . Br J Surg, 2007, 94(7): 860-865. 被引量:1
  • 8Verma V , Schwarz RE. Factors influencing perioperativw blood transfusions in patients with gastrointeslinal cancer [ J ]. J Surg Res, 2007, 141 (1) : 97 - 104. 被引量:1
  • 9Schreibcr GB, Busch MP, Kleinman Sit, et al. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study [J]. N Engl J Med, 1996, 334 (26): 1685-1690. 被引量:1
  • 10Sugita S, Sasaki A , Iwaki K , et al. Prognosis and postoperative lymphocyte count in patients with hepatoceilular carcinoma who received intraoperative allogenie blood transtusion : a retrospective study [ J ]. Eur J Surg Ontol, 2008, 34 (3) : 339 -345. 被引量:1

共引文献52

同被引文献30

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部